Amarantus BioScience Holdings, Inc. Stock
Equities
AMBS
US02300U2050
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -80.00% |
Sales 2014 | - | Sales 2015 | - | Capitalization | 8.57M 11.72M |
---|---|---|---|---|---|
Net income 2014 | -27M -36.9M | Net income 2015 | -25M -34.17M | EV / Sales 2014 | - |
Net cash position 2014 | 89K 122K | Net Debt 2015 | 2.96M 4.05M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.06
x | P/E ratio 2015 |
-0.15
x | Employees | 12 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 | |
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.000001 | 0.00% | 1,219,564 |
Delayed Quote OTC Markets, April 23, 2024 at 01:20 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-80.00% | 630 | |
+2.17% | 42.75B | |
+47.70% | 41.61B | |
+12.45% | 41.34B | |
-12.36% | 26.59B | |
+7.72% | 25.49B | |
-22.96% | 18.12B | |
+30.55% | 12.24B | |
-2.00% | 11.76B | |
+8.09% | 11B |
- Stock Market
- Equities
- AMBS Stock